Cocrystal Pharma, Inc. (COCP)
1.19
0.00 (0.00%)
USD |
NASDAQ |
Sep 23, 16:00
Cocrystal Pharma Cash from Operations (TTM) : -8.263M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.263M |
| March 31, 2026 | -7.995M |
| December 31, 2025 | -8.594M |
| September 30, 2025 | -9.308M |
| June 30, 2025 | -12.07M |
| March 31, 2025 | -13.44M |
| December 31, 2024 | -15.00M |
| September 30, 2024 | -15.31M |
| June 30, 2024 | -14.06M |
| March 31, 2024 | -16.20M |
| December 31, 2023 | -14.81M |
| September 30, 2023 | -17.25M |
| June 30, 2023 | -23.09M |
| March 31, 2023 | -21.12M |
| December 31, 2022 | -21.92M |
| September 30, 2022 | -19.21M |
| June 30, 2022 | -15.72M |
| March 31, 2022 | -14.57M |
| December 31, 2021 | -12.43M |
| September 30, 2021 | -12.85M |
| June 30, 2021 | -10.63M |
| March 31, 2021 | -9.864M |
| December 31, 2020 | -10.28M |
| September 30, 2020 | -8.500M |
| June 30, 2020 | -6.636M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.769M |
| December 31, 2019 | -1.563M |
| September 30, 2019 | -2.024M |
| June 30, 2019 | -2.955M |
| March 31, 2019 | -3.949M |
| December 31, 2018 | -8.045M |
| September 30, 2018 | -7.546M |
| June 30, 2018 | -7.692M |
| March 31, 2018 | -6.906M |
| December 31, 2017 | -6.880M |
| September 30, 2017 | -7.514M |
| June 30, 2017 | -7.894M |
| March 31, 2017 | -11.81M |
| December 31, 2016 | -13.80M |
| September 30, 2016 | -14.90M |
| June 30, 2016 | -14.93M |
| March 31, 2016 | -12.26M |
| December 31, 2015 | -9.779M |
| September 30, 2015 | -8.365M |
| June 30, 2015 | -6.657M |
| March 31, 2015 | -5.542M |
| December 31, 2014 | -5.763M |
| September 30, 2014 | -7.890M |
| June 30, 2014 | -7.077M |
| March 31, 2014 | -6.388M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | -207.00M |
| Fulcrum Therapeutics, Inc. | -65.78M |
| Definium Therapeutics, Inc. | -166.74M |